Is a complete BCBA/MRNA research report available?

No complete published report is available for bcba/MRNA (BCBA/MRNA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/MRNA (BCBA/MRNA)

Buenos Aires Stock Exchange: BCBA/MRNA · ARS

ARS 18,690

+640.75 (+3.5%)· Recorded snapshot

Market cap	131.5T
Revenue (ttm)	3.3T
Net income (ttm)	-4.7T
EPS (ttm)	-ARS 650
Volume	148,747

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.3T
Net income (ttm): -4.7T
EPS (ttm): -ARS 650
Market cap: 131.5T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-06
Employees	4,700
Employees change	-1,100
Employees growth	-18.97%
Enterprise value	ARS 122.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	No
ISIN number	AR0666228538
Last earnings date	2026-07-31
Last refreshed	2026-10-29
Market cap	ARS 131.5T
Next earnings date	2026-11-06
Price	ARS 18,690.00
Price currency	ARS
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/MRNA
Website	https://www.modernatx.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-06

Employees

4,700

Employees change

-1,100

Employees growth

-18.97%

Enterprise value

ARS 122.8T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

2010

Industry

Biotechnology

Is primary listing

ISIN number

AR0666228538

Last earnings date

2026-07-31

Last refreshed

2026-10-29

Market cap

ARS 131.5T

Next earnings date

2026-11-06

Price

ARS 18,690.00

Price currency

ARS

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

bcba/MRNA

Website

https://www.modernatx.com

Metric	Value
Earnings yield	-3.48%
EV/Sales	35.85x
FCF / EV yield	-1.5%
FCF yield	-1.4%
P/B ratio	13.12x
P/S ratio	39.82x
Price / tangible book value	13.44x

Metric

Value

Earnings yield

-3.48%

EV/Sales

35.85x

FCF / EV yield

-1.5%

FCF yield

-1.4%

P/B ratio

13.12x

P/S ratio

39.82x

Price / tangible book value

13.44x

Metric	Value
EBIT margin	-109.34%
EBITDA margin	-98.52%
Gross margin	-66.02%
Operating margin	-109.34%
Pretax margin	-138.55%
Profit margin	-141.43%
Profit per employee	ARS -993.2M
Revenue per employee	ARS 702.3M
ROA	-13.26%
ROA (5Y)	6.72%
ROCE	-28.91%
ROE	-39%
ROE (5Y)	22.02%
ROIC	-75.99%
ROIC (5Y)	40.43%
SBC / revenue	20.74%
Tax / revenue	2.87%

Metric

Value

EBIT margin

-109.34%

EBITDA margin

-98.52%

Gross margin

-66.02%

Operating margin

-109.34%

Pretax margin

-138.55%

Profit margin

-141.43%

Profit per employee

ARS -993.2M

Revenue per employee

ARS 702.3M

ROA

-13.26%

ROA (5Y)

6.72%

ROCE

-28.91%

ROE

-39%

ROE (5Y)

22.02%

ROIC

-75.99%

ROIC (5Y)

40.43%

SBC / revenue

20.74%

Tax / revenue

2.87%

Metric	Value
EPS growth quarters	1
EPS growth years	2
Net income growth quarters	1
Net income growth years	2
Revenue growth	-27.62%
Revenue growth (Q)	2.11%
Revenue growth (QoQ)	-62.72%
Revenue growth 3Y	-40.64%
Revenue growth 5Y	-20.51%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-27.62%

Revenue growth (Q)

2.11%

Revenue growth (QoQ)

-62.72%

Revenue growth 3Y

-40.64%

Revenue growth 5Y

-20.51%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -253.3B
Depreciation and amortization	ARS 371.5B
EBIT	ARS -3.6T
EBITDA	ARS -3.3T
EPS	ARS -649.72
Financing cash flow	ARS 905.2B
Free cash flow	ARS -1.8T
Free cash flow minus SBC	ARS -2.5T
Gross profit	ARS -2.2T
Income taxes	ARS 94.8B
Investing cash flow	ARS 1.3T
Net borrowing	ARS 891.1B
Net cash flow	ARS 656.3B
Net income	ARS -4.7T
Operating cash flow minus SBC	ARS -2.3T
Operating income	ARS -3.6T
Revenue	ARS 3.3T
Stock-based compensation	ARS 684.5B

Metric

Value

Capital expenditures

ARS -253.3B

Depreciation and amortization

ARS 371.5B

EBIT

ARS -3.6T

EBITDA

ARS -3.3T

EPS

ARS -649.72

Financing cash flow

ARS 905.2B

Free cash flow

ARS -1.8T

Free cash flow minus SBC

ARS -2.5T

Gross profit

ARS -2.2T

Income taxes

ARS 94.8B

Investing cash flow

ARS 1.3T

Net borrowing

ARS 891.1B

Net cash flow

ARS 656.3B

Net income

ARS -4.7T

Operating cash flow minus SBC

ARS -2.3T

Operating income

ARS -3.6T

Revenue

ARS 3.3T

Stock-based compensation

ARS 684.5B

Metric	Value
Altman Z-Score	2.62
Book value per share	ARS 25,103.81
Debt / equity	0.19
Goodwill	ARS 80.2B
Interest coverage	-58
Long-term assets	ARS 7.3T
Long-term liabilities	ARS 2.3T
Net cash (debt)	ARS 8.3T
Net cash / market cap	6.34%
Net cash growth	-16.87%
Net debt / equity	-0.83
Piotroski F-Score	2
Property, plant and equipment	ARS 4.2T
Shareholders' equity	ARS 10T
Tangible book value	ARS 9.8T
Tangible book value per share	ARS 24,506.01
Total assets	ARS 16.2T
Total cash	ARS 7.6T
Total debt	ARS 1.9T
Total liabilities	ARS 6.2T

Metric

Value

Altman Z-Score

2.62

Book value per share

ARS 25,103.81

Debt / equity

0.19

Goodwill

ARS 80.2B

Interest coverage

-58

Long-term assets

ARS 7.3T

Long-term liabilities

ARS 2.3T

Net cash (debt)

ARS 8.3T

Net cash / market cap

6.34%

Net cash growth

-16.87%

Net debt / equity

-0.83

Piotroski F-Score

Property, plant and equipment

ARS 4.2T

Shareholders' equity

ARS 10T

Tangible book value

ARS 9.8T

Tangible book value per share

ARS 24,506.01

Total assets

ARS 16.2T

Total cash

ARS 7.6T

Total debt

ARS 1.9T

Total liabilities

ARS 6.2T

Metric	Value
Asset turnover	0.19
Current assets	ARS 9T
Current liabilities	ARS 3.9T
Current ratio	2.29
Inventory turnover	14.23
Net working capital	ARS -2.7T
Quick ratio	2.07
Working capital	ARS 4.9T
Working capital turnover	837.76

Metric

Value

Asset turnover

0.19

Current assets

ARS 9T

Current liabilities

ARS 3.9T

Current ratio

2.29

Inventory turnover

14.23

Net working capital

ARS -2.7T

Quick ratio

2.07

Working capital

ARS 4.9T

Working capital turnover

837.76

Metric	Value
Buyback yield / dilution	-1.94%
Shareholder yield	-1.94%

Metric

Value

Buyback yield / dilution

-1.94%

Shareholder yield

-1.94%

Metric	Value
150-day SMA	ARS 8,010.47
1D price change	3.55%
1M price change	10.4%
1M total return	10.4%
1W price change	-9.93%
1W total return	-9.93%
1Y price change	813.94%
1Y return CAGR	815.32%
1Y total return	813.94%
20-day SMA	ARS 18,023.00
200-day SMA	ARS 6,917.13
3M price change	298.51%
3M total return	298.51%
50-day SMA	ARS 15,105.40
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 21,860.00
52-week high date	2026-10-21
52-week low	ARS 1,765.00
52-week low date	2025-11-21
6M price change	382.95%
6M total return	382.95%
All-time high	ARS 21,860.00
All-time high date	2026-10-21
All-time low	ARS 1,380.00
All-time low date	2025-04-21
Average true range (ATR)	ARS 1,766.18
Average volume	328.2K
Change from 52-week high	-14.5%
Change from 52-week low	958.92%
Change from all-time high	-14.5%
Change from all-time low	1,254.35%
Change from open	3.55%
Day's gap	0%
Dollar volume	ARS 2.8B
High price	ARS 18,960.00
Low price	ARS 17,970.00
Monthly RSI	80.85
Open price	ARS 18,050.00
Position in 52-week range	72.73%
Previous close	ARS 18,050.00
Price vs 150-day SMA	133.32%
Price vs 20-day SMA	3.7%
Price vs 200-day SMA	170.2%
Price vs 50-day SMA	23.73%
Relative volume	0.45
RSI	56.69
Sharpe ratio	1.68
Sortino ratio	6.48
Volume	148.7K
Weekly RSI	78.47
YTD price change	654.54%
YTD total return	654.54%

Metric

Value

150-day SMA

ARS 8,010.47

1D price change

3.55%

1M price change

10.4%

1M total return

10.4%

1W price change

-9.93%

1W total return

-9.93%

1Y price change

813.94%

1Y return CAGR

815.32%

1Y total return

813.94%

20-day SMA

ARS 18,023.00

200-day SMA

ARS 6,917.13

3M price change

298.51%

3M total return

298.51%

50-day SMA

ARS 15,105.40

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 21,860.00

52-week high date

2026-10-21

52-week low

ARS 1,765.00

52-week low date

2025-11-21

6M price change

382.95%

6M total return

382.95%

All-time high

ARS 21,860.00

All-time high date

2026-10-21

All-time low

ARS 1,380.00

All-time low date

2025-04-21

Average true range (ATR)

ARS 1,766.18

Average volume

328.2K

Change from 52-week high

-14.5%

Change from 52-week low

958.92%

Change from all-time high

-14.5%

Change from all-time low

1,254.35%

Change from open

3.55%

Day's gap

Dollar volume

ARS 2.8B

High price

ARS 18,960.00

Low price

ARS 17,970.00

Monthly RSI

80.85

Open price

ARS 18,050.00

Position in 52-week range

72.73%

Previous close

ARS 18,050.00

Price vs 150-day SMA

133.32%

Price vs 20-day SMA

3.7%

Price vs 200-day SMA

170.2%

Price vs 50-day SMA

23.73%

Relative volume

0.45

RSI

56.69

Sharpe ratio

1.68

Sortino ratio

6.48

Volume

148.7K

Weekly RSI

78.47

YTD price change

654.54%

YTD total return

654.54%

Metric	Value
Float	372M
Shares change (QoQ)	0.76%
Shares change (YoY)	1.94%
Shares held by insiders	6.74%
Shares held by institutions	80.51%
Short ratio	1.6 days

Metric

Value

Float

372M

Shares change (QoQ)

0.76%

Shares change (YoY)

1.94%

Shares held by insiders

6.74%

Shares held by institutions

80.51%

Short ratio

1.6 days

BCBA/MRNA (BCBA/MRNA)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/MRNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/MRNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/MRNA

Frequently asked questions